What we're reading, January 16, 2017: House follows Senate vote to begin Obamacare repeal process; President-elect Donald Trump teases Obamacare replacement to provide insurance for everyone; and acceptance of aid-in-dying legislation grows.
Despite any concerns Republicans may have had about repealing the Affordable Care Act (ACA) without a replacement ready to go, the House also voted to start the process of gutting the ACA. Reuters reported that the House has instructed committees to start drafting legislation that would repeal the ACA by January 27. This vote followed Senate approval. In addition to all Democrats voting against the measure, so did 9 Republicans. Once the legislation is drafted, it will need to be approved by both chambers and signed into law by then-President Donald J. Trump.
While there is no replacement yet for the ACA, Trump said he is close to completing a new healthcare law that would provide insurance for everyone. The Washington Post got the scoop with an exclusive phone call with Trump later on Saturday. The president-elect did not reveal any specifics about his plan, but it is unclear if his plan to expand the government’s involvement in healthcare will receive support from those in his own party. Trump also vowed to target pharmaceutical companies over drug prices.
With nearly 20% of Americans living in a state that has some aid-in-dying law, allowing terminally ill adults to end their own lives seems to have become more acceptable in the US. According to The New York Times, the concept of assisted suicide has had support from a substantial majority of Americans for at least 15 years. While the idea gains acceptance and state medical societies shift away from opposing the initiatives, the safeguards on passed legislation can make implementing the practice difficult.
Brodalumab Is Effective, Safe in Patients With Moderate to Severe Psoriasis
March 18th 2024Posters presented at the American Academy of Dermatology Annual Meeting demonstrated both short- and long-term efficacy and safety profiles of brodalumab in patients with moderate to severe psoriasis.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
AstraZeneca joins efforts to address high drug prices by capping out-of-pocket costs for its inhalers; Opill, the first OTC birth control pill, is now accessible through online sales; expansion prompts questions on the effectiveness and regulation of remote monitoring technology.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Health Equity and Access Weekly Roundup: March 16, 2024
March 16th 2024This week, the Center on Health Equity and Access highlighted expert opinions on a mental health paradigm shift in the workplace, the impact health care algorithms can have on patient outcomes, and social factors linked with hidradenitis suppurativa severity, in addition to addressing the health needs of justice-involved populations.
Read More